Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MS (Multiple Sclerosis)”

1,105 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,105 results

Not applicableStudy completedNCT03244696
What this trial is testing

Behavior and Activity Monitoring in MS

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Ohio State University 87
Not applicableStudy completedNCT00617383
What this trial is testing

AT RISK FOR MS - Clinical Conversion of Female Monozygotic Twins Discordant for CIS/MS

Who this might be right for
Multiple SclerosisClinically Isolated Syndrome
The University of Texas Health Science Center, Houston 3
Testing effectiveness (Phase 2)Study completedNCT01071083
What this trial is testing

Treatment Interruption of Natalizumab

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Biogen 175
Not applicableUnknownNCT03817073
What this trial is testing

Assessing Fatiguability of Tongue Muscles in MS

Who this might be right for
Muscle WeaknessFatigueMultiple Sclerosis+2 more
Thomas More Kempen 60
Not applicableUnknownNCT02352194
What this trial is testing

Physical Capacity and Rehabilitation of Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis (MS)
Assistance Publique - Hôpitaux de Paris 60
Post-approval studies (Phase 4)Study completedNCT00785473
What this trial is testing

Can Vitamin D Supplementation Prevent Bone Loss in Persons With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Osteoporosis
University Hospital of North Norway 80
Not applicableStudy completedNCT05334472
What this trial is testing

A Survey to Evaluate Early Experience From Patient and Care Partner on Injection and Device for KESIMPTA® Indicated for Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Novartis Pharmaceuticals 105
Testing effectiveness (Phase 2)Study completedNCT00086671
What this trial is testing

Safety and Effectiveness of Two Doses of ABT-874 as Compared to Placebo in Subjects With Multiple Sclerosis (MS)

Who this might be right for
Multiple Sclerosis
AbbVie (prior sponsor, Abbott) 215
Testing effectiveness (Phase 2)UnknownNCT00220428
What this trial is testing

T-Cell Vaccination in Multiple Sclerosis (MS)

Who this might be right for
Multiple Sclerosis
Sheba Medical Center 20
Post-approval studies (Phase 4)Ended earlyNCT02665221
What this trial is testing

Single Center, Open Label, Study of Preparation H on Erythema in Relapsing MS Patients Treated With PLEGRIDY

Who this might be right for
Multiple Sclerosis
NYU Langone Health 30
Large-scale testing (Phase 3)UnknownNCT02220244
What this trial is testing

Effect of MD1003 in Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
MedDay Pharmaceuticals SA 105
Testing effectiveness (Phase 2)WithdrawnNCT01086371
What this trial is testing

Rhythmic Auditory Stimulation and Walking Performance in Multiple Sclerosis (MS) Patients

Who this might be right for
Gait Disturbance in Multiple Sclerosis Patients
The Cleveland Clinic
Not applicableStudy completedNCT02198599
What this trial is testing

Mobility Enhancing Nursing Intervention

Who this might be right for
StrokeMultiple Sclerosis
Zurich University of Applied Sciences 140
Testing effectiveness (Phase 2)Study completedNCT03752307
What this trial is testing

Safety and Tolerability of ISX (Isoxsuprine HCL) in MS Relapses

Who this might be right for
Multiple Sclerosis
University of New Mexico 2
Large-scale testing (Phase 3)Study completedNCT01188811
What this trial is testing

Lipoic Acid for Secondary Progressive Multiple Sclerosis (MS)

Who this might be right for
Multiple Sclerosis, Chronic Progressive
VA Office of Research and Development 54
Testing effectiveness (Phase 2)Looking for participantsNCT07178431
What this trial is testing

MB-CART2019.1 in Refractory Multiple Sclerosis

Who this might be right for
Multiple SclerosisCAR T Cell Therapy
Miltenyi Biomedicine GmbH 26
Not applicableNot Yet RecruitingNCT07645937
What this trial is testing

Effects of Low-Load Blood Flow Restriction Exercise on Rectus Femoris Muscle Morphology in Individuals With Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis (MS) - Relapsing-remitting
Hanifi Bal 30
Early research (Phase 1)Not Yet RecruitingNCT07676266
What this trial is testing

C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy

Who this might be right for
Multiple Sclerosis (MS)Myasthenia Gravis (MG)Neuromyelitis Optica Spectrum Disorder+3 more
The Affiliated Hospital of Qingdao University 18
Early research (Phase 1)Study completedNCT01803867
What this trial is testing

An Intravenous Infusion Study of rHIgM22 in Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Acorda Therapeutics 72
Not applicableLooking for participantsNCT05227092
What this trial is testing

3D OPTIMIZED WMN MPRAGE Increased Detection of Focal Spinal Cord Lesion in Multiple Sclerosis (WHINUME)

Who this might be right for
Multiple Sclerosis
University Hospital, Bordeaux 60
Next Page